Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 10 | 2015 | 63 | 2.310 |
Why?
|
| Laparoscopy | 14 | 2021 | 304 | 2.020 |
Why?
|
| Hernia, Hiatal | 2 | 2021 | 21 | 1.400 |
Why?
|
| Obesity, Morbid | 5 | 2015 | 77 | 1.360 |
Why?
|
| Insulin Resistance | 7 | 2015 | 375 | 0.920 |
Why?
|
| Herniorrhaphy | 2 | 2021 | 50 | 0.730 |
Why?
|
| Blood Glucose | 2 | 2015 | 445 | 0.540 |
Why?
|
| Preoperative Care | 1 | 2015 | 143 | 0.520 |
Why?
|
| Weight Loss | 5 | 2015 | 259 | 0.490 |
Why?
|
| Obesity | 5 | 2015 | 1101 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 5 | 2001 | 274 | 0.430 |
Why?
|
| Insulin | 3 | 2011 | 660 | 0.400 |
Why?
|
| Heart Conduction System | 1 | 2009 | 31 | 0.390 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 36 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 590 | 0.350 |
Why?
|
| Heart Rate | 1 | 2009 | 264 | 0.350 |
Why?
|
| Postoperative Complications | 3 | 2015 | 891 | 0.310 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 500 | 0.300 |
Why?
|
| Glucose | 2 | 2007 | 381 | 0.290 |
Why?
|
| Homeostasis | 1 | 2007 | 305 | 0.280 |
Why?
|
| Retrospective Studies | 6 | 2021 | 4410 | 0.250 |
Why?
|
| Incidence | 2 | 2021 | 1114 | 0.250 |
Why?
|
| Humans | 26 | 2021 | 48594 | 0.230 |
Why?
|
| Male | 18 | 2015 | 23091 | 0.220 |
Why?
|
| Middle Aged | 14 | 2015 | 13423 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 168 | 0.220 |
Why?
|
| Surgical Mesh | 1 | 2021 | 47 | 0.220 |
Why?
|
| Esophagectomy | 1 | 2021 | 34 | 0.220 |
Why?
|
| Recurrence | 2 | 2021 | 492 | 0.210 |
Why?
|
| Adult | 12 | 2015 | 13144 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2001 | 161 | 0.200 |
Why?
|
| Female | 16 | 2015 | 26148 | 0.200 |
Why?
|
| Kupffer Cells | 2 | 2015 | 38 | 0.190 |
Why?
|
| Body Mass Index | 5 | 2011 | 858 | 0.190 |
Why?
|
| Aspirin | 1 | 2000 | 176 | 0.180 |
Why?
|
| Risk Factors | 2 | 2021 | 4208 | 0.170 |
Why?
|
| Adipose Tissue, White | 2 | 2008 | 69 | 0.160 |
Why?
|
| Adipose Tissue | 2 | 2010 | 281 | 0.150 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 47 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2011 | 3803 | 0.140 |
Why?
|
| Remission Induction | 1 | 2015 | 122 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 72 | 0.140 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 38 | 0.140 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 64 | 0.140 |
Why?
|
| Splenectomy | 2 | 2004 | 33 | 0.130 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 70 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 1926 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 5 | 2001 | 450 | 0.130 |
Why?
|
| Adenocarcinoma | 3 | 2001 | 325 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2006 | 557 | 0.110 |
Why?
|
| Prognosis | 1 | 2015 | 1244 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 31 | 0.100 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 40 | 0.100 |
Why?
|
| Omentum | 1 | 2010 | 13 | 0.100 |
Why?
|
| Cell Division | 3 | 2001 | 430 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2000 | 197 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 120 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 104 | 0.100 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 19 | 0.100 |
Why?
|
| Sodium Salicylate | 2 | 1999 | 2 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 169 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 828 | 0.100 |
Why?
|
| Sex Factors | 2 | 2009 | 843 | 0.100 |
Why?
|
| Hernia | 1 | 2009 | 11 | 0.100 |
Why?
|
| I-kappa B Proteins | 2 | 1999 | 39 | 0.090 |
Why?
|
| Peritoneal Lavage | 1 | 2009 | 3 | 0.090 |
Why?
|
| Colon, Sigmoid | 1 | 2009 | 6 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2000 | 450 | 0.090 |
Why?
|
| Diverticulitis | 1 | 2009 | 21 | 0.090 |
Why?
|
| Gastroplasty | 1 | 2008 | 13 | 0.090 |
Why?
|
| Linear Models | 1 | 2009 | 409 | 0.090 |
Why?
|
| Wounds, Stab | 1 | 2008 | 9 | 0.090 |
Why?
|
| Radiography | 1 | 2009 | 339 | 0.090 |
Why?
|
| Abdominal Injuries | 1 | 2008 | 20 | 0.090 |
Why?
|
| Age Factors | 2 | 2009 | 1417 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 33 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 53 | 0.080 |
Why?
|
| Immunoassay | 1 | 2007 | 56 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 142 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 242 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2000 | 571 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 602 | 0.080 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 69 | 0.070 |
Why?
|
| Nephrectomy | 1 | 2006 | 55 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 996 | 0.070 |
Why?
|
| Splenic Diseases | 1 | 2004 | 13 | 0.070 |
Why?
|
| Splenomegaly | 1 | 2004 | 22 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 430 | 0.070 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2004 | 23 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 546 | 0.070 |
Why?
|
| Inflammation | 1 | 2010 | 941 | 0.060 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2003 | 4 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 55 | 0.060 |
Why?
|
| Adrenalectomy | 1 | 2003 | 24 | 0.060 |
Why?
|
| G1 Phase | 2 | 2001 | 57 | 0.060 |
Why?
|
| Macrophages | 2 | 1999 | 916 | 0.060 |
Why?
|
| Apoptosis | 2 | 1999 | 1026 | 0.060 |
Why?
|
| S Phase | 2 | 2001 | 77 | 0.060 |
Why?
|
| Massachusetts | 1 | 2009 | 2014 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2003 | 104 | 0.060 |
Why?
|
| Cell Separation | 2 | 2000 | 147 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2003 | 39 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2009 | 2469 | 0.060 |
Why?
|
| Spleen | 1 | 2004 | 479 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 1572 | 0.060 |
Why?
|
| Immunophilins | 1 | 2001 | 1 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 7 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 44 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2001 | 659 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2008 | 682 | 0.050 |
Why?
|
| Chromones | 1 | 2000 | 18 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2000 | 114 | 0.050 |
Why?
|
| Cyclin D1 | 1 | 2000 | 25 | 0.050 |
Why?
|
| Morpholines | 1 | 2000 | 66 | 0.050 |
Why?
|
| Flavonoids | 1 | 2000 | 70 | 0.050 |
Why?
|
| Young Adult | 1 | 2009 | 3621 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 23 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 29 | 0.050 |
Why?
|
| Ubiquitins | 1 | 1999 | 41 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2006 | 823 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 81 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 75 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1999 | 28 | 0.050 |
Why?
|
| Aged | 4 | 2009 | 10797 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2003 | 535 | 0.050 |
Why?
|
| Ischemia | 1 | 2000 | 170 | 0.050 |
Why?
|
| Endotoxins | 1 | 1999 | 70 | 0.040 |
Why?
|
| Lipopolysaccharides | 4 | 2006 | 629 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 374 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2000 | 189 | 0.040 |
Why?
|
| Adipocytes | 2 | 2010 | 214 | 0.040 |
Why?
|
| Animals | 7 | 2015 | 17856 | 0.040 |
Why?
|
| Liver | 1 | 2000 | 701 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2015 | 52 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 2901 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 2015 | 20 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 137 | 0.040 |
Why?
|
| Laparotomy | 2 | 2008 | 36 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2015 | 41 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 97 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 56 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2008 | 402 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2015 | 85 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 458 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 329 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 191 | 0.030 |
Why?
|
| Mice | 3 | 2015 | 9050 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 189 | 0.030 |
Why?
|
| Swine | 2 | 2006 | 298 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 357 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2006 | 268 | 0.030 |
Why?
|
| Mutation | 1 | 2000 | 2255 | 0.030 |
Why?
|
| Length of Stay | 2 | 2006 | 618 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 269 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2008 | 1443 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2006 | 2063 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 820 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2001 | 2730 | 0.030 |
Why?
|
| Chemokines | 1 | 2010 | 90 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 1999 | 27 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2000 | 350 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 796 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 475 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 517 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 171 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 81 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 171 | 0.020 |
Why?
|
| Lipolysis | 1 | 2008 | 35 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 179 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 50 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 67 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 774 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 359 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 59 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 220 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 53 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 78 | 0.020 |
Why?
|
| Rats | 2 | 2000 | 1810 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 20 | 0.020 |
Why?
|
| Abdomen | 1 | 2006 | 94 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 365 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 3189 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 944 | 0.020 |
Why?
|
| Palpation | 1 | 2004 | 9 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 18 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1580 | 0.020 |
Why?
|
| Hand | 1 | 2004 | 47 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1996 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 369 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2004 | 61 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2004 | 49 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 2060 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1130 | 0.010 |
Why?
|
| Proteins | 1 | 2008 | 713 | 0.010 |
Why?
|
| Mitogens | 1 | 2001 | 12 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2001 | 9 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 28 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2001 | 32 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2000 | 12 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 809 | 0.010 |
Why?
|
| Sirolimus | 1 | 2001 | 67 | 0.010 |
Why?
|
| Bile | 1 | 2000 | 15 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 2000 | 11 | 0.010 |
Why?
|
| Reperfusion | 1 | 2000 | 25 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2001 | 106 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 45 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2001 | 145 | 0.010 |
Why?
|
| Ibuprofen | 1 | 1999 | 17 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 36 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 51 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1999 | 5 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 302 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1534 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1999 | 24 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1999 | 117 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 117 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 541 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1999 | 578 | 0.010 |
Why?
|
| Cell Line | 1 | 1999 | 1975 | 0.010 |
Why?
|